Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Filings indexed 1,661 across all filing types
Latest filing 2020-09-29 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and in accordance with the Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying the closure of the trading window pursuant to SEBI regulations ahead of the announcement of financial results for the quarter and half year ended 30 September 2020. It is a regulatory compliance announcement related to insider trading restrictions and does not contain any financial data or results itself. The document length is short (1732 characters) and it serves as an intimation rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance announcements and notifications.
2020-09-29 English
Morepen Laboratories Limited has informed BSE about the Loss of Share Certificates of the Company
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (National Stock Exchange of India and Bombay Stock Exchange) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references compliance with Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is about notifying the exchanges of lost share certificates and related administrative details. There is no financial data, no report attached or referenced as being published, no management discussion, no earnings or audit information, and no mention of voting or AGM materials. This type of document is a regulatory announcement related to share certificate loss and administrative compliance, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-09-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates and the issuance of duplicate share certificates. It references compliance with Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content consists of notifications about specific shareholders who have lost share certificates and the issuance of duplicates, including folio numbers, certificate numbers, and shareholder names. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is a regulatory announcement informing the exchanges and the public about share certificate status changes, which fits the category of a Regulatory Filing (RNS) as it does not fit into more specific categories like share issue or capital change (SHA) or director dealings (DIRS).
2020-09-25 English
Morepen Laboratories Limited has informed BSE about the Loss of Share Certificates and Issuance of Duplicate Share Certificates by the Company
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates and the issuance of duplicate share certificates. It references compliance with Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content includes detailed information about shareholders who have lost share certificates and the issuance of duplicates, including folio numbers, certificate numbers, and shareholder names. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is a regulatory announcement informing the exchanges and the public about share certificate status changes, which fits the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Share Issue/Capital Change or Director's Dealing. The document length is 7555 characters, which is sufficient for a detailed regulatory filing but does not constitute a financial report or presentation.
2020-09-25 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and BSE Limited) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content is about notifying the stock exchanges of lost share certificates and related administrative details. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is a regulatory announcement related to share certificate loss, which does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is a regulatory compliance filing informing the exchange of a specific event. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-21 English
Morepen Laboratories Limited has informed BSE about the Loss of Share Certificates of the Company
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates by certain shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is about informing the exchanges of these events, not about financial results, management changes, or other report types. It is a regulatory announcement related to share certificates but does not fit into categories like share issue, capital change, or director dealings. It is a formal regulatory filing informing the stock exchanges of a compliance matter. Therefore, the best fitting category is Regulatory Filings (RNS). The document length is about 5095 characters, and it is a direct communication, not a report or announcement of a report publication.
2020-09-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.